|
Interventional radiologists have found that a subgroup of patients with critical limb ischemia, the most severe form of peripheral arterial disease (PAD), may avoid amputation through the use of drug-eluting stents on the smaller arteries below the knee, according to a study released at this week’s Society of Interventional Radiology's (SIR) Annual Scientific Meeting in Tampa, Fla.
Testing patients for peripheral arterial disease (PAD) via abnormal ankle brachial index (ABI) exams can identify patients at risk for future cardiac events who were not considered in the high-risk category with Framingham risk assessments, according to results of a clinical trial presented at the 35th annual scientific meeting of the Society of Interventional Radiology's in Tampa, Fla.
Volcano, a developer of products for the diagnosis of coronary and peripheral artery disease, has entered into a non-exclusive, global resale agreement with Siemens Healthcare.
Interventional radiologists are establishing how to use stem cells to create new or more blood vessels to treat peripheral arterial disease (PAD) in individuals with extensively narrowed or clogged arteries. Recent successful techniques use imaging to view and locate transplanted stem cells, and to confirm that they remain alive in the body once injected, according to a study presented at the Society of Interventional Radiology (SIR) annual conference this week in San Diego.
The use of common screening tests like the ankle brachial index (ABI), along with traditional risk scoring systems, such as the Framingham Risk Score (FRS), could prevent thousands of MIs in individuals who were not originally thought to be at high risk, according to findings presented at the 2009 meeting of the Society of Interventional Radiology (SIR) in San Diego this week.
|
Bone marrow stem cells suspended in X-ray-visible microbubbles can help in treating peripheral arterial disease (PAD) patients by increasing the number of blood vessels, according to research presented at the Society of Interventional Radiology's 35th Annual Scientific Meeting in Tampa, Fla. this week.
A strategy of systematic coronary angiography can positively impact the long-term outcome of peripheral arterial disease surgical patients at medium to high risk, according to a study in the Sept. 8 issue of the Journal of the American College of Cardiology.
Cook Medical and Angiotech Pharmaceuticals received CE Mark approval Monday for their polymer-free Zilver PTX drug-eluting peripheral stent to treat blockages in the legs caused by peripheral arterial disease.
Treating critical limb ischemia in peripheral arterial disease (PAD) patients with below-the-knee angioplasty is thwarted by restenosis, the need for repeat treatments and the continued progression of atherosclerotic disease, leading to tissue death and amputation. However, interventional radiologists have found that drug-eluting stents (DES) lessen the rate of repeat procedures to open these small arteries, according to results presented at the Society of Interventional Radiology (SIR) annual meeting in San Diego this week.
|